Back to search

Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and TRP-2.

Data up to Jan 2025

Published2001
Citations69
References24

Total Citations Per Year

Abstract

References (24)

Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

1998 • 2,916 citations

DNA Vaccines: Immunology, Application, and Optimization

2000 • 1,212 citations

T-cell apoptosis detected in situ during positive and negative selection in the thymus

1994 • 1,071 citations

High-efficiency gene transfer into skeletal muscle mediated by electric pulses

1999 • 901 citations

gp100/pmel 17 Is a Murine Tumor Rejection Antigen: Induction of “Self”-reactive, Tumoricidal T Cells Using High-affinity, Altered Peptide Ligand

1998 • 490 citations

Identification of Tyrosinase-related Protein 2 as a Tumor Rejection Antigen for the B16 Melanoma

1997 • 405 citations

Fundamentals of electroporative delivery of drugs and genes

1999 • 393 citations

High Avidity CTLs for Two Self-Antigens Demonstrate Superior In Vitro and In Vivo Antitumor Efficacy

1999 • 388 citations

Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy

1996 • 289 citations

Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptidesin vivo: Implications for tumor vaccines with melanoma-associated antigens

1996 • 250 citations

Coupling and Uncoupling of Tumor Immunity and Autoimmunity

1999 • 245 citations

Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle.

1996 • 222 citations

An autologous oral DNA vaccine protects against murine melanoma

2000 • 161 citations

Development of Cancer Immunotherapies Based on Identification of the Genes Encoding Cancer Regression Antigens

1996 • 132 citations

The immunogenicity of single and combination DNA vaccines against tuberculosis

2000 • 128 citations

Genetic vaccination with 'self' tyrosinase-related protein 2 causes melanoma eradication but not vitiligo

2000 • 116 citations

Tumor antigens recognized by cytolytic T lymphocytes: Present perspectives for specific immunotherapy

1993 • 109 citations

Bleomycin-Mediated Electrochemotherapy of Metastatic Melanoma

1996 • 108 citations

Genetic vaccination against the melanocyte lineage-specific antigen gp100 induces cytotoxic T lymphocyte-mediated tumor protection.

1998 • 78 citations

Induction of tumor antigen-specific immunity using plasmid DNA immunization in mice

1999 • 72 citations

Intratumoral delivery of IL-12 gene by polyvinyl polymeric vector system to murine renal and colon carcinoma results in potent antitumor immunity

1999 • 66 citations

Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes

2000 • 64 citations

Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8+ and CD4+ T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity

1999 • 61 citations

Dendritic Cells Infected with a Vaccinia Vector Carrying the Human gp100 Gene Simultaneously Present Multiple Specificities and Elicit High-Affinity T Cells Reactive to Multiple Epitopes and Restricted by HLA-A2 and -A3

2000 • 54 citations

Cited By (0)

Loading...
Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and… (2001) – PubMed | Metascience Observatory Explorer